BRIEF-Seattle Genetics, Astellas announce updated enfortumab vedotin phase 1 data in metastatic urothelial cancer – Reuters

UPDATE 1-Drugmaker Perrigo says CEO Hendrickson plans to retire

June 5 Drugmaker Perrigo Co Plc said on Monday that Chief Executive John Hendrickson planned to retire, an announcement that comes a little more than a year after the company veteran got the top job.

More here:
BRIEF-Seattle Genetics, Astellas announce updated enfortumab vedotin phase 1 data in metastatic urothelial cancer - Reuters

Related Posts